There are ways to tell if something is AI generated, but theyre going to get better and keep changing
Clinical trials NSCLC The randomized, global, open-label, phase 3 TROPION-Lung01 trial (NCT04656652) evaluated dato-DXd in adults with locally advanced or metastatic NSCLC (with and without actionable genomic alterations) who were treated with at least one prior therapy, including an approved targeted therapy and platinum-based chemotherapy
The potential benefits of retatrutide for women are broad, spanning weight management, metabolic health, and conditions that disproportionately affect females
The drug targets both GLP-1 and another hormone, amylin
Ethical Considerations and Future Outlook The discussion around the mots c retatrutide stack highlights the cutting edge of metabolic research
24 , 148153 (2022) E